250
Participants
Start Date
June 7, 2022
Primary Completion Date
October 1, 2025
Study Completion Date
March 1, 2028
Hydrocortisone
Patients are randomised to either placebo or hydrocortisone supplemental doses in situations of stress. Patients will continue prednisolone treatment and tapering hereof according to current clinical guidelines for PMR/GCA , prednisolone is not part of the intervention.
Placebo for hydrocortisone
Patients are randomised to either placebo or hydrocortisone supplemental doses in situations of stress. Patients will continue prednisolone treatment and tapering hereof according to current clinical guidelines for PMR/GCA , prednisolone is not part of the intervention.
RECRUITING
Department of Medical Endocrinology, Copenhagen University Hospital, Rigshospitalet, Copenhagen
NOT_YET_RECRUITING
Department of Endocrinology, Aarhus University Hospital, Aarhus
NOT_YET_RECRUITING
Department of Endocrinology, Odense University Hospital, Odense
Aarhus University Hospital
OTHER
Odense University Hospital
OTHER
Ulla Feldt-Rasmussen
OTHER